FDA Clears First-in-Class Emicizumab for Hemophilia A FDA Clears First-in-Class Emicizumab for Hemophilia A

Hemlibra is a first-in-class bispecific monoclonal antibody that bridges activated factor IX and X to replace the missing factor VIII.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Alert Source Type: news